👏 A truly encouraging session today at the #ISTHCongress on the ISTH haemophilia guidelines. The open and constructive dialogue reflects the progress we’ve made collectively as a global community. This evolving landscape highlights the value of ongoing collaboration and mutual respect among all stakeholders.
What a great plenary lecture of Leslie Raffini at #ISTH2025 Pediatric Thrombosis: a lot has been done in 30 years, but still a lot to be done in the coming years!
Critical appraisal of the ISTH Haemophilia Guidelines session, with some robust discussion and interesting perspectives, our very own Dr Jane Mason delivering a great presentation “Dissecting the Guidelines” the clinician experience #ISTH2025@THANZBlood
The Victor Blanchette Memorial Lecture @isth Dr. B was a mentor, dear friend and guide….. so fortunate to have met him and worked with him. Dr Carcao have him a fitting tribute. A true giant in the field of pediatric hematology…. @SickKidsNews
Late breaking abstract session at #ISTH2025. COBRRA results are in! 50% reduction in bleeding with Apixaban use for acute VTE compared to Rivaroxaban. @THANZBlood members were co-investigators on this study, an enormous effort.
@evsfaustino beautiful summary of 2-hit hypothesis for CVC related VTE in critically ill kids, role of inflammation, need to decouple hemostasis from thrombosis, potential role for XI / XIIa inhibitors, and maybe adolescents aren’t just young adults… #ISTH2025@THANZBlood
Dr Uma Athale gave an excellent SOA update on thromboprophylaxis in pediatric cancer ?who, when, with what and for how long…more questions than answers right now! Work to be done #ISTH2025@THANZBlood
A fitting tribute to the life’s work of Claire McLintock delivered in the Claire McLintock Memorial Lecture by Jennifer Curnow. Congratulations Jennifer, @THANZBlood is proud of you! #ISTH2025
Dr Isabelle Gouin-Thibault gave an update on the ongoing Delphi process to develop @isth guidelines for the challenging area of UFH monitoring and nomogram based dose adjustment. #ISTH2025
ISTH is inviting all clinicians involved in anticoagulation management to participate in the following survey: https://t.co/N8MYBsGdBw
These are the outcomes they are interested in. Jump on the link and fill it out! #ISTH2025@THANZBlood
Kelsey Bria from Washington university school of medicine presented their outcome analysis of >500 adult patients presenting to ED with PE, showed than in the intermediate risk group early commencement of anticoagulant therapy reduced mortality. #ISTH2025
In a Star Wars themed presentation, Julianne Chong, recipient of an @THANZBlood travel grant, laid down the case for Anticoagulation Stewardship (ACS) in all hospital settings, and invited participation in an @isth endorsed survey to examine variation in current ACS practice.
The session on Vascular Anomalies and emerging targeted therapies highlighted the Haematologists essential role as part of the team caring for this complex group of patients. Adult hospital based MDT services are desperately needed. @THANZBlood
SOA on distal DVT by Dr. Merriman at #ISTH2024. Many potential management options
1) No anticoagulation and serial US
2) Anticoagulation for 2 to 6 weeks
3) Anticoagulation for 3 months
Depends to the risk of recurrent VTE and bleeding 🩸 See below 👇 @THANZBlood
Great talk from Huyen Tran at #ISTH2024 summarising landscape of haemophilia therapies. @THANZBlood members are out in force on day 4 of the meeting!